Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity

Published:January 06, 2014DOI:
      Although cholinesterase inhibitors have been frequently used in the treatment of Alzheimer disease, its effects on serum cholinesterase concentrations have been rarely described. We described significant depression of serum cholinesterase levels due to cholinesterase inhibitor toxicity from redundant use of donepezil and rivastigmine in a 78-year-old man. Recovery of serum cholinesterase level was noted upon drug discontinuation and cholinergic symptom resolution. Serum cholinesterase level can be used as a biomarker for central cholinesterase inhibitor toxicity.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cummings J.L.
        Use of cholinesterase inhibitors in clinical practice: evidence based recommendations.
        Am J Geriatr Psychiatry. 2003; 11: 131-145
        • Lanctot K.L.
        • Herrmann N.
        • Yau K.K.
        • Khan L.K.
        • Liu B.A.
        • LouLou M.M.
        • et al.
        Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta analysis.
        CMAJ. 2003; 169: 557-564
        • Park-Wyllie L.Y.
        • Mamdani M.M.
        • Li P.
        • Gill S.S.
        • Laupacis A.
        • Juurlink D.N.
        Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
        PLoS Med. 2009; 6: e1000157
        • Haug K.H.
        • Bogen I.L.
        • Osmundsen H.
        • Walaas I.
        • Fonnum F.
        Effects oncholinergic markers in rat brain and blood after short and prolonged administration of donepezil.
        Neurochem Res. 2005; 30: 1511-1520
        • Szilagvi N.K.
        • Nemeth A.
        • Martini E.
        • Lendvai B.
        • Venter V.
        Serum and CSF cholinesterase activity in various kinds of dementia.
        Eur Arch Psychiatry Neurol Sci. 1987; 236: 309-311